Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression ofÂ Churg-Strauss syndrome

Article ID	Journal	Published Year	Pages	File Type
3198259	Journal of Allergy and Clinical Immunology	2013	12 Pages	PDF

Abstract

These findings support the hypothesis that the presence or absence of autoantibodies influences the clinical expression and severity of CSS.

Keywords

FDA CSS MPA AERS P-ANCA LTRA ANCA IIF microscopic polyangiitis Leukotriene receptor antagonist Antineutrophil cytoplasmic autoantibodies US Food and Drug Administration Indirect immunofluorescence Risk difference Churg-Strauss syndrome Adverse Event Reporting System myeloperoxidase odds ratio Clinical features Wegener granulomatosis

Related Topics

Life Sciences Immunology and Microbiology Immunology

Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression ofÂ Churg-Strauss syndrome

Authors

Bridget MBChB, Susan MBChB, Richard FRACP, Mark MApplStats, Harold MD, Richard DSc,